Neurotrophic Signaling
Studied for its rapid upregulation of BDNF and NGF in neural tissue models.
Overview
Semax is a synthetic heptapeptide derived from ACTH(4-10), the melanocortin core of adrenocorticotropic hormone, extended with a stabilizing Pro-Gly-Pro sequence. It is studied as a nootropic and neuroprotective compound, with particular research interest in its rapid upregulation of BDNF and NGF.
Suria's Semax is synthesized to high purity and independently verified prior to release, giving researchers a consistent starting point for neurotrophic and cerebral-ischemia research models.
Research Use Only. Not for human or veterinary use.
Specifications
Third-Party Testing
Available third-party analytical documentation for Semax can be reviewed for applicable batches through Suria's Batch Documentation system. We believe documentation should be held to the same standard as the research it supports.
Certificates of Analysis will be available at time of launch.
Research Highlights
Studied for its rapid upregulation of BDNF and NGF in neural tissue models.
A frequently examined compound in stroke and neuroprotection research.
Investigated as a nootropic in models of focus and cognitive adaptation.
A C-terminal Pro-Gly-Pro motif designed to resist rapid enzymatic degradation.
Storage
Store as specified above, protected from light and moisture, until ready for reconstitution.
Store at 2–8°C and use within the recommended window for your protocol.
Avoid repeated freeze-thaw cycles to help preserve peptide integrity across a research protocol.
Research Use Only. Not for human consumption.
Frequently Asked Questions
Batch Documentation